Hydroxyzine

Half-Life (t½)
PO: 3h
Formula
C21H27ClN2O2
Molecular Weight
374.91 g/mol
PubChem CID
3658
Aliases
Atarax, Vistaril

Pharmacological Mechanism

First-generation H1 antagonist with anxiolytic + sedating + antiemetic activity. Common alternative to benzodiazepines for anxiety due to no addiction potential. Anticholinergic burden — Beers-list problematic. Cetirizine is the active metabolite.

Half-Life & Elimination Curve (PO: 3h)

100%50%25%12.5%0%0h0×t½3h1×t½6h2×t½9h3×t½12h4×t½15h5×t½0×t½ (0h): 100% remaining (~22 µg/L)1×t½ (3h): 50% remaining (~11 µg/L)2×t½ (6h): 25% remaining (~5.5 µg/L)3×t½ (9h): 12.5% remaining (~2.75 µg/L)4×t½ (12h): 6.3% remaining (~1.38 µg/L)5×t½ (15h): 3.1% remaining (~0.688 µg/L)
Plasma (PO)t½ Decay (3h)Effect Site (ke0)
  • 0×t½0h100% (22 µg/L)
  • 1×t½3h50% (11 µg/L)
  • 2×t½6h25% (5.5 µg/L)
  • 3×t½9h12.5% (2.75 µg/L)
  • 4×t½12h6.3% (1.38 µg/L)
  • 5×t½15h3.1% (0.688 µg/L)
Elimination t½3h (PO)
Rate Constant (ke)0.231 h⁻¹
Time to Peak (Tmax)1.22h
Est. Peak (Cmax)22 µg/L
Clearance (CL)277 L/h
97% Washout (5×t½)15h

Dosing Guidelines

Pharmacokinetic Parameters

Receptor Binding & Occupancy

Pathways It Modulates

Target Organ Systems

Chemical Structure & Identifiers

References